Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001514354 | SCV001722180 | benign | Cohen syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568024 | SCV003739794 | uncertain significance | Inborn genetic diseases | 2021-07-22 | criteria provided, single submitter | clinical testing | The c.1303-4A>G intronic alteration consists of a A to G substitution 4 nucleotides before coding exon 9 in the VPS13B gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001514354 | SCV002079465 | benign | Cohen syndrome | 2020-05-26 | no assertion criteria provided | clinical testing |